“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s… Read More »5 Stocks Under $10 With Big Upside Potential – Including 2 Microcap Biotech Stocks
Two penny stocks that boast “Strong Buy” consensus ratings from the analyst community and massive upside potential.
When it comes to the five biotech penny stocks to watch this quarter highlighted in today’s article, the author emphasizes that “These aren’t just names… Read More »There’s Good Reason To Watch These 5 Biotech Penny Stocks This Quarter
When it comes to biotech investing in 2021, healthcare stock analysts at RBC advised in a recent report that “Many pandemic-related influences are setting up the sector for outperformance but several factors could still work against the group, making individual stock selection a key priority…”
One billion dollars. Big things happen when a company reaches this threshold in annual sales.
“The fact that more than 9 months of this year have been focused on the space is unfounded. In fact, I don’t remember one industry in recent history that has so captivated the stock market as much as this,” says the author of today’s article of the biotech space – and biotech penny stocks in particular.
Heading into an earnings season in which many companies will be posting much lower earnings as a result of the pandemic.
“Make no mistake: These stocks are risky. Nonetheless, each of these companies has a few factors in its favor aside from being popular with retail traders, so if you’re looking for a high-risk and high-reward stock to add to your portfolio, one of these might be worth buying,”
“The health care sector, some biotech stocks in particular, are looking to explode in 2021,” declares the author of today’s article, who further notes that “There have been some breakout companies as a result of the coronavirus pandemic, but other catalysts will be playing into the expected gains as well.”